Articles From: Otonomy Reports Third Quarter 2014 Financial Results and Provides Corporate Update to Amphastar Pharmaceuticals Reports Revenues of $59.7 Million for the Third Quarter Ended September 30, 2014


http://media.marketwire.com/attachments/200806/439977_IMImmuCellLogoRGB300x40.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158037&ProfileId=051205&sourceType=1 PORTLAND, ME --
Sign-up for ImmuCell Announces Financial Results for Third Quarter of 2014 investment picks
AUBURN HILLS, Mich.
Sign-up for BorgWarner Declares Quarterly Dividend investment picks
AG Mortgage Investment Trust, Inc. (NYSE:MITT) announced today that its board of directors has declared a quarterly cash dividend of $0.51563 per share on its Series A 8.25% Cumulative Redeemable Preferred Stock (NYSE: MITTPRA). The dividend is payable on December 17, 2014 to holders of record on November 28, 2014.
Sign-up for AG Mortgage Investment Trust, Inc. Announces Preferred Stock Dividends Payable on December 17, 2014 investment picks
Board Concludes that Revised Proposal Significantly Undervalues ShoreTel and is Not in the Best Interest of Stockholders SUNNYVALE, Calif.
Sign-up for ShoreTel's Board of Directors Unanimously Rejects Mitel's Revised Unsolicited Proposal investment picks
DALLAS, Nov.
Sign-up for Texas Capital Bancshares, Inc. Announces Common Stock Offering investment picks
Manning & Napier, Inc. (NYSE: MN), (“Manning & Napier” or “the Company”) today reported preliminary assets under management (AUM) of $50.3 billion at October 31, 2014, compared with $51.1 billion at September 30, 2014 and $50.8 billion at December 31, 2013.
Sign-up for Manning & Napier, Inc. Reports October 31, 2014 Assets Under Management investment picks
http://media.marketwire.com/attachments/201411/81703_horizonpharma.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158415&ProfileId=051205&sourceType=1 DUBLIN, IRELAND --
Sign-up for Horizon Pharma plc Announces Clinical Data on RAYOS(R) (Prednisone) Delayed-Release Tablets and VIMOVO(R) (Naproxen/Esomeprazole Magnesium) to Be Presented at the American College of Rheumatology Annual Meeting investment picks
Dillard’s, Inc. (NYSE: DDS) will announce results for the 13 and 39 weeks ended November 1, 2014 before the open of the New York Stock Exchange tomorrow, Thursday, November 13 th .
Sign-up for Dillard’s, Inc. to Report Third Quarter Results investment picks
BEACHWOOD, Ohio , Nov.
Sign-up for DDR Exits Joint Venture in Buffalo investment picks
REDWOOD CITY, Calif., Nov.
Sign-up for Dermira Reports Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
GREENSBORO, N.C. , Nov.
Sign-up for Tanger Prices $250 Million 3.75% Senior Notes Due 2024 investment picks
Silicon Labs (NASDAQ: SLAB), a leading provider of wireless connectivity solutions for the Internet of Things , today introduced next-generation EZRadio ® and EZRadioPRO ® wireless ICs offering industry-leading power efficiency, wireless range and flexibility.
Sign-up for Silicon Labs Expands Sub-GHz Wireless Portfolio to Support 802.15.4/4g Connectivity investment picks
MOUNTAIN VIEW, Calif.
Sign-up for Synopsys Announces Earnings Release Date for Fourth Quarter and Fiscal Year 2014 investment picks
CHARLESTON, S.C., Nov.
Sign-up for Benefitfocus to Present at the Goldman Sachs US Emerging/SMID Cap Growth Conference investment picks
http://media.marketwire.com/attachments/201211/98749_netapp.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1158372&ProfileId=051205&sourceType=1 SUNNYVALE, CA --
Sign-up for NetApp Accelerates Customers' Use of the Cloud With New Products on Amazon Web Services investment picks
The Marketing Alliance, Inc. (OTC: MAAL) (“TMA”), today announced that its Board of Directors authorized a $0.21 per share cash dividend for shareholders of record on December 12, 2014, to be paid on or about January 30, 2015.
Sign-up for The Marketing Alliance Announces Annual Cash Dividend of $0.21 Per Share investment picks
Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company developing PRX302 for the treatment of the symptoms of benign prostatic hyperplasia (BPH, enlarged prostate) and for the treatment of localized low to intermediate risk prostate cancer, today announced financial results for the three and nine months ended September 30, 2014.
Sign-up for Sophiris Bio Reports Third Quarter Financial Results investment picks
CBRE Group, Inc. (NYSE:CBG) has been awarded the H.
Sign-up for CBRE Group, Inc. Receives Prestigious Global Innovators Award from CoreNet Global investment picks
Griffon Corporation (“Griffon” or the “Company”) (NYSE:GFF) today reported results for the fourth quarter and fiscal year ended September 30, 2014.
Sign-up for Griffon Corporation Announces Fourth Quarter and Annual Results investment picks
LAKE FOREST, Ill., Nov.
Sign-up for Stericycle to Present at NASDAQ Conference in December investment picks
COMMERCE, Calif.
Sign-up for Smart & Final Stores, Inc. Reports Third Quarter 2014 Results investment picks
– Confirmation of Plans to Initiate Phase 2 Active Comparator Study for RT002 in 2014 – NEWARK, Calif., Nov.
Sign-up for Revance Therapeutics Releases Third Quarter 2014 Results investment picks
GAINESVILLE, Fla., Nov.
Sign-up for AGTC Announces Financial Results for the First Quarter Ended September 30, 2014 investment picks
NEW BRUNSWICK, N.J. , Nov.
Sign-up for Magyar Bancorp, Inc. Announces Fourth Quarter And Year End Financial Results investment picks
RANCHO CUCAMONGA, Calif., Nov.
Sign-up for Amphastar Pharmaceuticals Reports Revenues of $59.7 Million for the Third Quarter Ended September 30, 2014 investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Otonomy Reports Third Quarter 2014 Financial Results and Provides Corporate Update to Amphastar Pharmaceuticals Reports Revenues of $59.7 Million for the Third Quarter Ended September 30, 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent